EPO Patents = 1

Forward Citations = 2

Loading Chart...

17 inventors (with patents filed for the assignee):

Michael S Kay (3 out of 7 patents)

Brett D Welch (3 out of 5 patents)

Ashok Bajji (2 out of 11 patents)

4. Kirill Ostanin (2 out of 8 patents)

5. Debra Muir Eckert (2 out of 9 patents)

6. Michael Thomas Jacobsen (2 out of 2 patents)

7. Damon Papac (1 out of 1 patent)

8. Hariprasad Vankayalapati (1 out of 50 patents)

9. Matthew T Weinstock (1 out of 7 patents)

10. Mark Shenderovich (1 out of 3 patents)

11. Christopher L Cioffi (1 out of 1 patent)

12. Neil Moss (1 out of 1 patent)

13. Dean Li (1 out of 14 patents)

14. Rena McKinnon (1 out of 1 patent)

15. James Nicholas Francis (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 11414442 - ARF6 inhibitors and related methods (2022-08-16),

2. 10849901 - Arf6 inhibitors and methods of synthesis and use thereof (2020-12-01),

3. 10765754 - Compositions and methods related to inhibition of respiratory syncytial virus entry (2020-09-08),

4. 10487121 - D-peptide inhibitors of HIV entry and methods of use (2019-11-26),

5. 10189878 - Ebolavirus pre-hairpin intermediate mimics and methods of use (2019-01-29),

Navigen, Inc. is a leading biotechnology company specializing in the development of innovative therapies for rare genetic diseases. With cutting-edge research and advanced technology, Navigen is dedicated to improving the lives of patients and families affected by these conditions. Their mission is to bring hope and healing to those in need through groundbreaking treatments and compassionate care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 13 2026

5 Patents

#247 in Salt Lake City, UT

#642 in Utah

#50,294 in US

Salt Lake City, UT, United States of America

Navigen, Inc.